SLC2A1 and obesity disorder: Various studies have tied the effectiveness of daruhaldi with obesity work by Kim et al. [42] shows that berberine treatment enhances AMPK activity in adipocytes, resulting in elevated GLUT1 expression and improved glucose uptake.